News | September 15, 2023
Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
For the treatment of Superficial Femoral Artery
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
Chief Imam of All India Imam Organization, Dr. Imam Umer Ahmed Ilyas, evinces keen interest in the eradication of Thalassemia & Sickle Cell Disease
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Women of all ages will get round-the-clock access to comprehensive treatment
Subscribe To Our Newsletter & Stay Updated
